PCM
TRIL

Pentwater Capital Management’s Trillium Therapeutics Inc. TRIL Stock Holding History

Pentwater Capital Management’s Portfolio TRIL Stock Details TRIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,140,000
Closed -$55.1M – 231
2021
Q3 		$55.1M Buy
+3,140,000
New +$55.1M 0.56% 21